DrugPatentWatch Database Preview
Profile for Canada Patent: 2529761
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2529761
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | May 3, 2027 | Siga Technologies | TPOXX | tecovirimat |
Start Trial | Jul 23, 2027 | Siga Technologies | TPOXX | tecovirimat |
Start Trial | Jun 18, 2024 | Siga Technologies | TPOXX | tecovirimat |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |